VaramirStart free · no cardSign in
ADMA as of Oct 31 · 05:33 ET
ADMANasdaqBiological Products, (No Diagnostic Substances)

Adma Biologics, Inc. · Brief

Next report

4 days

Nov 4 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±12.5%
avg realized
±8.0%
Mar 3 '25±15.0%▲+7.45%×0.50
May 7 '25±12.2%▼−10.21%×0.83
Aug 6 '25±13.1%▼−9.65%×0.74
Q3 FY25±16.3%▼−8.72%×0.54
Jan 12 '26±6.8%▼−0.11%×0.02
Q1 FY26±10.9%▼−3.19%×0.29
May 6 '26±14.1%▼−15.97%×1.14
Q2 FY26±11.7%▲+8.64%×0.74
quarterimplied−20%0+20%realized×
Q2 FY26±11.7%▲+8.64%×0.74
May '26±14.1%▼−15.97%×1.14
Q1 FY26±10.9%▼−3.19%×0.29
Jan '26±6.8%▼−0.11%×0.02
Q3 FY25±16.3%▼−8.72%×0.54
Aug '25±13.1%▼−9.65%×0.74
2 older reports
May '25±12.2%▼−10.21%×0.83
Mar '25±15.0%▲+7.45%×0.50
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 3

7disclosed supplier and customer ties in SEC filingsSEC filings
323managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

9 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
0.61%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ADMA report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±10.8% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.